SSI Innovations launches medical robotics surgery system in India : The Tribune India

SSI Innovations launches medical robotics surgery system in India

The company in a statement said that the dominant current robotic system is expensive and associated with a steep learning curve, resulting in the limited availability

SSI Innovations launches medical robotics surgery system in India

Photo for representation only. — File photo

New Delhi, January 19

Medical robotic technology firm SS Innovations on Tuesday launched its SSI multi-arm novel tele-robotic assistance surgical system in the country at a price of Rs 4-5 crore.

The company in a statement said that the dominant current robotic system is expensive and associated with a steep learning curve, resulting in the limited availability.

"The price of the system will be around Rs 4 to 5 crore. Initially, once we go into the commercial production we will be able to produce between 150-200 robotics systems in the first year. Our goal will be to ramp up the production as we launch our products globally," SSI Chairman and CEO Sudhir P Srivastava said.

"Robotics shall be the future of surgery, and my vision is to create a technologically advanced system that will be cost-effective, easy to use, and can be applied to all surgical specialities. Thus, benefiting most patients around the world," Srivastava said.

Compared to conventional surgery, robotic surgery results in smaller incisions, that reduces pain, scarring and leads to quicker recovery, he added.

The MANTRA (multi-arm novel tele robotic assistance) system was recently utilised for the first in human pilot study at Rajiv Gandhi Cancer Institute, where the surgeons successfully completed 18 complex Urology, Gynaecology and General Surgery procedures in less than a month, the statement said.

"The dedicated team of engineers and scientists at SS Innovations have been working hard under Dr Srivastava's guidance for the past few years to develop a cost-effective robotic surgical system. I congratulate them on this launch", Rajiv Gandhi Cancer Institute Medical Director Dr Sudhir Rawal said. — PTI

Tribune Shorts


Top News

Cough syrups by India's Maiden Pharma potentially tied to deaths in Gambia: WHO

‘Contaminated’ Indian medicines linked to deaths of 66 children in Gambia: WHO

Health Ministry launches probe into four alleged substandard...

No talks with Pakistan; Modi govt won't tolerate terrorism, Amit Shah says in J-K

No talks with Pakistan; Modi govt won't tolerate terrorism, Amit Shah says in J-K's Baramulla

Addressing a rally, Shah asks whether terrorism has ever ben...

Donald Blome second US official to visit Pakistan-occupied Kashmir since April

Donald Blome second US official to visit Pakistan-occupied Kashmir since April

MEA had reacted sharply to Ilham Omar’s visit to PoK

Pilot killed as army helicopter crashes in Arunachal Pradesh's Tawang

Pilot killed as army helicopter crashes in Arunachal Pradesh's Tawang

The Ministry of Defence spokesperson from Tezpur says the mi...


Cities

View All